MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    Computerized cognitive training in advanced Parkinson’s disease: preliminary feasibility data of an ongoing randomized controlled trial

    P. Olgemöller, E. Kalbe, C. Hennen, M. Barbe, M. Hellmich, AK. Folkerts (Cologne, Germany)

    Objective: To analyse the feasibility and effects on cognitive- and non-cognitive outcomes, and prediction of responsiveness of a computerized cognitive training (CT) in comparison to…
  • 2023 International Congress

    The effect of lumboperitoneal shunt surgery on patients with iNPH plus Parkinson’s disease

    T. Tsunemi, T. Shimada, A. Sakukrai, M. Nakajima, N. Hattori (Toyoo, Japan)

    Objective: To investigate the effect of lumboperitoneal shunt surgery on patients with iNPH comorbid with Parkinson’s disease Background: Comorbid Parkinson’s disease (PD) in idiopathic normal…
  • 2023 International Congress

    Istradefylline therapy for PD plus oromandibular dystonia

    NAO. Kanzato, SAT. Mochizuki (Haearu-cho, Okinawa, Japan)

    Objective: To clarify the dopaminergic system link between parkinson's disease (PD) and oromadibular dystonias (OMDy) co-occur, and the effect of istradefylline (IST) therapy. Background: OMDy are…
  • 2023 International Congress

    Eye tracking paradigm to identify disease-specific behavioral biomarkers in neurodegeneration

    M. Habibi, B. Coe, D. Brien, H. Riek, A. Janzen, W. Oertel, D. Munoz (Marburg, Germany)

    Objective: Rapid-eye movement (REM) sleep behavior disorder (RBD) has been identified as the most specific and common prodromal stages of α-synucleinopathies (αSYN) such as Parkinson's…
  • 2023 International Congress

    Gender differences in REM Sleep Behavior Disorder in Parkinson’s disease

    EL. Ungureanu, ș. Diaconu, A. Zârnoveanu, R. Filip, M. Cușnir, B. Ciopleiaș, C. Falup-Pecurariu (Brasov, Romania)

    Objective: To study the gender differences in probable REM Sleep Behavior Disorder (RBD) and other sleep characteristics in a cohort of Parkinson’s disease (PD) patients.…
  • 2023 International Congress

    Is an integrated Parkinson’s Dementia Service the way forward?

    A. Rafeeq, C. Thomas, B. Mohamed, J. Adenwalla, S. Page, R. Lewis-Morton, S. Mahon, T. Williams (Cardiff, United Kingdom)

    Objective: To illustrate the role of a single team in managing all facets of Parkinson’s Background: The Cardiff and Vale Parkinson’s service is an integrated,…
  • 2023 International Congress

    DaT-Scans Have Limited Utility in Predicting Treatment Response to Ventriculoperitoneal Shunts in Normal Pressure Hydrocephalus

    J. Ma, M. Hamed, D. Victor, T. Kay, M. Salgado (Brooklyn, USA)

    Objective: To determine usefulness of DaT-SPECT imaging in the management of normal pressure hydrocephalus (NPH). Background: Dopamine transporter single-photon emission computed tomography (DaT-SPECT) imaging is…
  • 2023 International Congress

    Alopecia in females with young onset Parkinson’s Disease: an exploratory survey

    K. Fisher, E. Clifford, N. Piniella, A. Leder, R. Gallagher (Glen Head, USA)

    Objective: To explore the symptoms of females with young onset Parkinson's Disease (YOPD), specifically alopecia, in comparison to females with traditional onset Parkinson’s Disease (TOPD).…
  • 2023 International Congress

    The effect of continuous subcutaneous apomorphine infusion on vitamin B metabolites and plasma homocysteine in Parkinson’s disease patients

    O. Phokaewvarangkul, N. Kantachadvanich, R. Bhidayasiri (Bangkok, Thailand)

    Objective: To evaluate the plasma level of vitamin B and homocysteine between PD patients with conventional medications and PD patients with CSAI. Background: Although levodopa…
  • 2023 International Congress

    Exploring the complementary approach of a standardized osteopathic treatment protocol on sleep quality in Parkinsons disease: A randomized controlled study

    S. Yao, J. Difrancisco-Donoghue, A. Leder, J. Mancini, J. Docherty (Old Westbury, USA)

    Objective: To investigate the complementary effects of a standardized Osteopathic Manipulative Treatment (OMT) Protocol on sleep quality using the Pittsburgh Sleep Index (PSQI) Background: Parkinson’s…
  • « Previous Page
  • 1
  • …
  • 97
  • 98
  • 99
  • 100
  • 101
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Survey-Based study of marijuana used in Parkinson’s Disease patients
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley